| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13177* | 2021 |
| Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Q Zhang, P Bastard, Z Liu, J Le Pen, M Moncada-Velez, J Chen, M Ogishi, ... Science 370 (6515), eabd4570, 2020 | 2135 | 2020 |
| TLR3 deficiency in patients with herpes simplex encephalitis SY Zhang, E Jouanguy, S Ugolini, A Smahi, G Elain, P Romero, D Segal, ... science 317 (5844), 1522-1527, 2007 | 1287 | 2007 |
| SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ... Cell 185 (3), 467-484. e15, 2022 | 904 | 2022 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 719 | 2021 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 439 | 2021 |
| Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis RP de Diego, V Sancho-Shimizu, L Lorenzo, A Puel, S Plancoulaine, ... Immunity 33 (3), 400-411, 2010 | 357 | 2010 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 329 | 2021 |
| Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency V Sancho-Shimizu, RP De Diego, L Lorenzo, R Halwani, A Alangari, ... The Journal of clinical investigation 121 (12), 4889-4902, 2011 | 329 | 2011 |
| p62 and NDP52 proteins target intracytosolic Shigella and Listeria to different autophagy pathways S Mostowy, V Sancho-Shimizu, MA Hamon, R Simeone, R Brosch, ... Journal of Biological Chemistry 286 (30), 26987-26995, 2011 | 323 | 2011 |
| Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity Y Guo, M Audry, M Ciancanelli, L Alsina, J Azevedo, M Herman, ... Journal of Experimental Medicine 208 (10), 2083-2098, 2011 | 317 | 2011 |
| Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre … CD Russell, CJ Fairfield, TM Drake, L Turtle, RA Seaton, DG Wootton, ... The Lancet Microbe 2 (8), e354-e365, 2021 | 284 | 2021 |
| Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood M Herman, M Ciancanelli, YH Ou, L Lorenzo, M Klaudel-Dreszler, ... Journal of Experimental Medicine 209 (9), 1567-1582, 2012 | 278 | 2012 |
| A global effort to define the human genetics of protective immunity to SARS-CoV-2 infection JL Casanova, HC Su, L Abel, A Aiuti, S Almuhsen, AA Arias, P Bastard, ... Cell 181 (6), 1194-1199, 2020 | 252 | 2020 |
| Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study RK Gupta, EM Harrison, A Ho, AB Docherty, SR Knight, M van Smeden, ... The Lancet Respiratory Medicine 9 (4), 349-359, 2021 | 207 | 2021 |
| Human Toll‐like receptor‐dependent induction of interferons in protective immunity to viruses SY Zhang, E Jouanguy, V Sancho‐Shimizu, H Von Bernuth, K Yang, ... Immunological reviews 220 (1), 225-236, 2007 | 187 | 2007 |
| TLR3 immunity to infection in mice and humans SY Zhang, M Herman, MJ Ciancanelli, RP de Diego, V Sancho-Shimizu, ... Current opinion in immunology 25 (1), 19-33, 2013 | 183 | 2013 |
| Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the … CI Bloom, TM Drake, AB Docherty, BJ Lipworth, SL Johnston, ... The Lancet Respiratory Medicine 9 (7), 699-711, 2021 | 164 | 2021 |
| Human TBK1: a gatekeeper of neuroinflammation L Ahmad, SY Zhang, JL Casanova, V Sancho-Shimizu Trends in molecular medicine 22 (6), 511-527, 2016 | 163 | 2016 |
| Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study TM Drake, AM Riad, CJ Fairfield, C Egan, SR Knight, R Pius, ... The Lancet 398 (10296), 223-237, 2021 | 142 | 2021 |
